Procaps Group, S.A Other Non-Current Liabilities 2020-2023 | PROCF
Procaps Group, S.A other non-current liabilities from 2020 to 2023. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Procaps Group, S.A Annual Other Non-Current Liabilities (Millions of US $) |
2022 |
$57 |
2021 |
$128 |
2020 |
$4 |
2020 |
$197 |
2019 |
$ |
2019 |
$ |
2018 |
$ |
Procaps Group, S.A Quarterly Other Non-Current Liabilities (Millions of US $) |
2023-09-30 |
$33 |
2023-06-30 |
$42 |
2023-03-31 |
$46 |
2022-12-31 |
$57 |
2022-09-30 |
$89 |
2022-06-30 |
$118 |
2022-03-31 |
$107 |
2021-12-31 |
$128 |
2021-09-30 |
$37 |
2021-06-30 |
$165 |
2021-03-31 |
$225 |
2020-12-31 |
$4 |
2020-09-30 |
$197 |
2020-06-30 |
$197 |
2020-03-31 |
$197 |
2019-12-31 |
$197 |
2019-09-30 |
|
2019-06-30 |
|
2019-03-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-DRUGS |
$0.125B |
$0.410B |
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|